| Pharmacokinetic drug-drug interaction and their implication in clinical management C Palleria, A Di Paolo, C Giofrè, C Caglioti, G Leuzzi, A Siniscalchi, ... Journal of research in medical sciences: the official journal of Isfahan …, 2013 | 525 | 2013 |
| The pharmacological bases of the antiangiogenic activity of paclitaxel G Bocci, A Di Paolo, R Danesi Angiogenesis 16, 481-492, 2013 | 206 | 2013 |
| Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer A Falcone, G Masi, G Allegrini, R Danesi, E Pfanner, IM Brunetti, ... Journal of clinical oncology 20 (19), 4006-4014, 2002 | 192 | 2002 |
| Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients A Di Paolo, R Danesi, A Falcone, L Cionini, F Vannozzi, G Masi, ... Annals of oncology 12 (9), 1301-1306, 2001 | 150 | 2001 |
| Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). R Danesi, C Agen, U Benelli, AD Paolo, D Nardini, G Bocci, F Basolo, ... Clinical cancer research: an official journal of the American Association …, 1997 | 136 | 1997 |
| Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5, 6-dihydrouracil after conventional and reduced test dose in cancer patients G Bocci, R Danesi, A Di Paolo, F Innocenti, G Allegrini, A Falcone, ... Clinical cancer research 6 (8), 3032-3037, 2000 | 124 | 2000 |
| Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study C Scatena, M Roncella, A Di Paolo, P Aretini, M Menicagli, G Fanelli, ... Frontiers in oncology 8, 452, 2018 | 118 | 2018 |
| Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib G Bocci, A Falcone, A Fioravanti, P Orlandi, A Di Paolo, G Fanelli, ... British journal of cancer 98 (10), 1619-1629, 2008 | 113 | 2008 |
| Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification A Di Paolo, G Bocci Current oncology reports 9, 109-114, 2007 | 110 | 2007 |
| Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer F Loupakis, C Cremolini, A Fioravanti, P Orlandi, L Salvatore, G Masi, ... British journal of cancer 104 (8), 1262-1269, 2011 | 108 | 2011 |
| Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post‐marketing clinical study on healthy volunteers M Del Tacca, G Pasqualetti, A Di Paolo, A Virdis, G Massimetti, G Gori, ... British journal of clinical pharmacology 68 (1), 34-42, 2009 | 99 | 2009 |
| Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer R Danesi, F De Braud, S Fogli, TM De Pas, A Di Paolo, G Curigliano, ... Pharmacological reviews 55 (1), 57-103, 2003 | 98 | 2003 |
| Pharmacological issues of linezolid: an updated critical review A Di Paolo, P Malacarne, E Guidotti, R Danesi, M Del Tacca Clinical pharmacokinetics 49, 439-447, 2010 | 96 | 2010 |
| A pharmacokinetic‐based test to prevent severe 5‐fluorouracil toxicity G Bocci, C Barbara, F Vannozzi, A Di Paolo, A Melosi, G Barsanti, ... Clinical Pharmacology & Therapeutics 80 (4), 384-395, 2006 | 94 | 2006 |
| Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo G Bocci, R Danesi, U Benelli, F Innocenti, A Di Paolo, S Fogli, ... Cancer chemotherapy and pharmacology 43, 205-212, 1999 | 94 | 1999 |
| A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients G Allegrini, A Falcone, A Fioravanti, MT Barletta, P Orlandi, F Loupakis, ... British journal of cancer 98 (8), 1312-1319, 2008 | 92 | 2008 |
| Concise review: chronic myeloid leukemia: stem cell niche and response to pharmacologic treatment E Arrigoni, M Del Re, S Galimberti, G Restante, E Rofi, S Crucitta, ... Stem cells translational medicine 7 (3), 305-314, 2018 | 90 | 2018 |
| An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma S Fogli, R Danesi, F Innocenti, A Di Paolo, G Bocci, C Barbara, ... Therapeutic drug monitoring 21 (3), 367, 1999 | 90 | 1999 |
| Sequence effect of irinotecan and fluorouracil treatment on pharmacokinetics and toxicity in chemotherapy-naive metastatic colorectal cancer patients A Falcone, A Di Paolo, G Masi, G Allegrini, R Danesi, M Lencioni, ... Journal of clinical oncology 19 (15), 3456-3462, 2001 | 87 | 2001 |
| Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers G Allegrini, T Di Desidero, MT Barletta, A Fioravanti, P Orlandi, B Canu, ... Angiogenesis 15, 275-286, 2012 | 83 | 2012 |
